Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations, ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Here’s everything you need to know about the latest Google Gemini 2.0 update, including new AI models like Flash, Pro, and ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

M Investment Round Highlights D-Fend’s Global Leadership in Counter-Drone Technology Across Industries With drones becoming ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Launched by homegrown real estate portal MOGUL.sg, MAIA is a virtual property assistant designed to streamline property ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Hugging Face is a leading AI platform known for its open source tools and model repositories.

An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.